• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Proteon Therapeutics

edit

Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases.

The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics.

Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures.

The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

Recent Milestones

edit

• 
  Proteon Therapeutics received $15.2M in Venture Round funding. (8/12/11)
  Posted 8/12/11 at 6:35pm via fiercebiotech.com
• 
  Proteon Therapeutics received $50M in Series B funding. (5/28/09)
  Posted 6/17/09 at 12:20pm via proteontherapeutics.com
• 
  Proteon Therapeutics received $12M in Series A funding. (9/6/07)
  Posted 6/17/09 at 12:20pm via proteontherapeutics.com
• 
  Proteon Therapeutics added Timothy P. Noyes as President and CEO.
  Posted 6/17/09 at 12:20pm

Videos

Screenshots

edit

Above: Proteon Therapeutics Screenshot -- #1
Uploaded: 6/17/09

Sources

1. PROTEON THERAPEUTICS COMPLETES $12 MILLION FINANCING AND HIRES CFO (proteontherapeutics.com) [edit]
2. Proteon Therapeutics Completes Second Closing of Equity Financing (proteontherapeutics.com) [edit]
3. Proteon Therapeutics grabs $15.2M financing (fiercebiotech.com) [edit]